Carcinoembryonic Antigen (CEA) Market
- 2026 年市場規模
- USD 1,286.4 Mn
- 2033 年預估規模
- USD 2,071.8 Mn
- 年複合成長率 CAGR
- 7.1%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Carcinoembryonic Antigen (CEA) Market, By Product (Reagents and Kits, Instruments/Analyzers, and Consumables), By Technology (Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Electrochemiluminescence Immunoassay (ECLIA), and Others), By Application (Cancer Diagnosis, Treatment Monitoring, Recurrence Monitoring, and Research Applications), By End User (Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The global carcinoembryonic antigen (CEA) market is estimated to be valued at USD 1,286.4 Mn in 2026 and is expected to reach USD 2,071.8 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 7.1% from 2026 to 2033. Carcinoembryonic antigen (CEA), a glycoprotein known for its functions in cell adhesion, stands as one of the oldest known tumor biomarkers in oncology. This particular molecule is only expressed throughout embryonic development, but it reasserts itself and proliferates in certain types of cancer, such as colorectal, lung, breast, and pancreas tumors, as well as some gastrointestinal and various other kinds of cancers. The global carcinoembryonic antigen (CEA) market involves a range of diagnostic kits, diagnostic devices, chemical reagents, and analytical tools which can identify as well as quantify the level of the CEA concentration found within blood, samples of urine and tissue for purpose of cancer diagnoses, its follow-up care and follow-up observation for recurrence. It also consists of other kinds of analytical equipment that can monitor the concentration of cancerous biomarkers.
Global trends of increasing the awareness and understanding of cancer diseases and the growing utilization of early-stage biomarker detection methods have driven this market. The market is bolstered by leaps and advances in immunoassay techniques such as CLIA (chemiluminescence immunoassay), ELISA (enzyme-linked immunosorbent assay), and ECL (electrochemiluminescence), alongside a gradual expansion in the availability of health care facilities and the implementation of precision medicine programs that, collectively, drive expansion across the in-vitro diagnostics (IVD) landscape.
Market Dynamics
The global carcinoembryonic antigen (CEA) market is driven by high global incidence and prevalence of colorectal, gastric, breast, lung and other cancers resulting in high need for tumor biomarker for screening, diagnosis, staging, therapy monitoring and recurrence assessment. Besides these growth factors, market adoption is being fueled by the growth in personalized and targeted therapy and increasing demand for automated immunoassay instruments like ECL and CLIA and increasing biomarker development. Moreover, technological advances in tumor biomarker and companion diagnostics development are expanding the adoption of CEA assay across the clinical settings.
However, a number of constraints are present in the market, such as low specificity of carcinoembryonic antigen (CEA) as an independent biomarker, high costs associated with advanced diagnosis systems, regulatory challenges and problems in standardization of assay. Nevertheless, growing interest in multi-biomarker diagnostic panel, rapid increase in the market for point of care diagnostics, investment in liquid biopsy technologies and the growing number of cancer screening programmes, especially in developing countries will offer new opportunities for growth in carcinoembryonic antigen (CEA) market.
Key Features of the Study
• This report provides in-depth analysis of the global carcinoembryonic antigen (CEA) market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global carcinoembryonic antigen (CEA) market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, bioMérieux SA, Sysmex Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Fujirebio Holdings, Inc., DiaSorin S.p.A., and Boditech Med Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global carcinoembryonic antigen (CEA) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global carcinoembryonic antigen (CEA) market
Market Segmentation
• Product Insights (Revenue, USD Mn, 2021 - 2033)
o Reagents and Kits
o Instruments/Analyzers
o Consumables
• Technology Insights (Revenue, USD Mn, 2021 - 2033)
o Chemiluminescence Immunoassay (CLIA)
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Electrochemiluminescence Immunoassay (ECLIA)
o Others
• Application Insights (Revenue, USD Mn, 2021 - 2033)
o Cancer Diagnosis
o Treatment Monitoring
o Recurrence Monitoring
o Research Applications
• End User Insights (Revenue, USD Mn, 2021 - 2033)
o Hospitals
o Diagnostic Laboratories
o Academic and Research Institutes
o Others
• Regional Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o F.Hoffmann-La Roche Ltd.
o Abbott Laboratories
o Siemens Healthineers AG
o Danaher Corporation
o bioMérieux SA
o Sysmex Corporation
o Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
o Fujirebio Holdings, Inc.
o DiaSorin S.p.A.
o Boditech Med Inc.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Carcinoembryonic Antigen (CEA) Market, By Product
Global Carcinoembryonic Antigen (CEA) Market, By Technology
Global Carcinoembryonic Antigen (CEA) Market, By Application
Global Carcinoembryonic Antigen (CEA) Market, By End User
Global Carcinoembryonic Antigen (CEA) Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Industry Trends
4. Global Carcinoembryonic Antigen (CEA) Market, By Product, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Reagents and Kits
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Instruments/Analyzers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Consumables
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Carcinoembryonic Antigen (CEA) Market, By Technology, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Chemiluminescence Immunoassay (CLIA)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Enzyme-Linked Immunosorbent Assay (ELISA)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Electrochemiluminescence Immunoassay (ECLIA)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Carcinoembryonic Antigen (CEA) Market, By Application, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Cancer Diagnosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Treatment Monitoring
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Recurrence Monitoring
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Research Applications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Carcinoembryonic Antigen (CEA) Market, By End User, 2021-2033, (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Diagnostic Laboratories
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Carcinoembryonic Antigen (CEA) Market, By Region, 2021 - 2033, Value (USD Mn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
o South Africa
o North Africa
o Central Africa
9. Competitive Landscape
o F.Hoffmann-La Roche Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Abbott Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Siemens Healthineers AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Danaher Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o bioMérieux SA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Sysmex Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Fujirebio Holdings, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o DiaSorin S.p.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Boditech Med Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
10. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
11. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on Carcinoembryonic Antigen (CEA) Market' - Global forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們